Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sun Pharmaceutical has received the US Food and Drug Administration (FDA) approval for marketing its generic alfuzosin hydrochloride extended release tablets.
Subscribe to our email newsletter
Sun Pharma’s alfuzosin hydrochloride extended release tablets are the generic version of Sanofi-aventis’ Uroxatral extended release tablets.
Uroxatral is approved to treat signs and symptoms of benign prostatic hyperplasia (BPH) also known as enlarged prostate.
Uroxatral relaxes the muscles in the prostate and bladder neck, making it easier to urinate.